Navigator Medicines operate as a biotech company.
Navigator Medicines has raised $100.0M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
Navigator Medicines's investors include RA Capital Management, Forbion Capital Partners.
Navigator Medicines is headquartered in Scotch Plains, United States.
Navigator Medicines operate as a biotech company.
Navigator Medicines is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Navigator Medicines — Funding & Investors." VCBacked, August 27, 2024, https://www.vcbacked.co/company/navigator-medicines. Accessed August 15, 2026.
VCBacked. (2024). Navigator Medicines — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/navigator-medicines
{{cite web |title=Navigator Medicines — Funding & Investors |url=https://www.vcbacked.co/company/navigator-medicines |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated